Medicosbiotech Inc. develops bio-based wound healing compounds and functional cosmetics using biotechnology. They optimize production of high-value recombinant spider silk proteins through metabolic engineering and synthetic biology, creating innovative pharmaceuticals. Their products, including Dr.GRAFT and SP:DER:MA, are exported to 14 countries and certified by FDA, CPNP, PMDA, and NMPA.